Editing Dense deposit disease (MGRS)

{{tp|p=32447506|t=2020. Treatment-resistant nephrotic syndrome in dense deposit disease: complement-mediated glomerular capillary wall injury?|pdf=|usr=}}{{32447506}}
{{tp|p=26704376|t=2016. Proliferative C4 Dense Deposit Disease, Acute Thrombotic Microangiopathy, a Monoclonal Gammopathy, and Acute Kidney Failure.|pdf=|usr=}}{{26704376}}
{{tp|p=38076230|t=2023. C3 glomerulopathies: dense deposit disease and C3 glomerulonephritis.|pdf=|usr=}}{{38076230}}
{{tp|p=33329990|t=2020. Eculizumab for pediatric dense deposit disease: A case report and literature review.|pdf=|usr=}}{{33329990}}
{{tp|p=29724182|t=2018. Favorable effect of bortezomib in dense deposit disease associated with monoclonal gammopathy: a case report.|pdf=|usr=}}{{29724182}}
{{tp|p=22403278|t=2012. Eculizumab for dense deposit disease and C3 glomerulonephritis.|pdf=|usr=}}{{22403278}}
{{tp|p=18971369|t=2009. Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients.|pdf=|usr=}}{{18971369}}
{{tp|p=29515303|t=2018. Dense Deposit Disease Involving C3 and C4d Deposits.|pdf=|usr=}}{{29515303}}
{{tp|p=23091320|t=2012. Dense deposit disease in Korean children: a multicenter clinicopathologic study.|pdf=|usr=}}{{23091320}}
{{tp|p=22677550|t=2012. Pathology after eculizumab in dense deposit disease and C3 GN.|pdf=|usr=}}{{22677550}}
{{tp|p=21601923|t=2011. Dense deposit disease.|pdf=|usr=}}{{21601923}}
{{tp|p=17675665|t=2007. New approaches to the treatment of dense deposit disease.|pdf=|usr=}}{{17675665}}
{{tp|p=24161036|t=2013. Dense deposit disease and C3 glomerulopathy.|pdf=|usr=}}{{24161036}}